AlphAIalphai — Financial news for AI agents
StockNASDAQ · US · USDHealthcare · Medical Instruments & Supplies

$PDEX

PRO DEX INC

Price · $PDEXvia TradingView
AI sentiment · 7d1 articles
AUG 23net (bullish − bearish)AUG 29
Bullish
0
Neutral
1
Bearish
0
Insider · 30dAll trades →

No SEC Form 4 filings for $PDEX in the last 30 days.

See all $PDEX insider activity →
Top stories · $PDEXMore →
AUG 28·SEC EDGAR 8-KLow

PRO DEX INC (PDEX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

PRO DEX INC (PDEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Compensation of Chief Executive Officer and Chief Financial Officer . On August 26, 2026, the Compensation Committee approv

MAY 26·SEC EDGAR

Van Kirk Richard Lee Jr sold $119K of PDEX

Van Kirk Richard Lee Jr (Chief Executive Officer) sold 1,918 shares of PRO DEX INC (PDEX) at $62.22 ($0.12M total) on 2026-05-21 under a Rule 10b5-1 trading plan.

PDEX sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning PDEX (PRO DEX INC). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent PDEX coverage spans financial news, corporate actions and insider activity.

What's driving PDEX

  • Bonuses tied to sales growth and FY‑2026 performance may signal confidence in near‑term revenue, modestly supporting the stock.

    SEC EDGAR 8-K · Aug 28, 2026

  • Insider selling disclosed for PDEX; likely modest near-term sentiment impact unless follow-on selling accelerates.

    SEC EDGAR · May 26, 2026

  • Pro-Dex (PDEX) reported Q1 earnings and revenues significantly above estimates, indicating strong operational performance. This positive surprise may lead to short-term stock appreciation, especially among traders focusing on earnings catalysts.

    Zacks Commentary · Oct 30, 2025

  • Pro-Dex, Inc. (PDEX) reported earnings and revenue below analyst estimates for Q2 2025, with surprises of -23.40% and -2.27%, respectively. The miss indicates potential short-term weakness.

    Zacks Commentary · Sep 4, 2025

  • Pro-Dex reported a 16% revenue increase in Q4 FY2025, indicating growth, but faces margin pressures. The positive revenue trend may support a short-term price increase, but margin concerns could limit upside.

    Motley Fool · Sep 4, 2025

alphai scores every news story that mentions PDEX with an AI model for sentiment and relevance, and aggregates insider trades from PRO DEX INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $PDEX

Score
AUG 28$PDEXLowSEC EDGAR 8-K

PRO DEX INC (PDEX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

PRO DEX INC (PDEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Compensation of Chief Executive Officer and Chief Financial Officer . On August 26, 2026, the Compensation Committee approv

1 min read
SEP 4$PDEXMedMotley Fool

Pro-Dex Revenue Jumps 16% in Fiscal Q4

Pro-Dex ( NASDAQ:PDEX ) , a developer and manufacturer of powered surgical instruments for medical device OEMs, released its Q4 FY2025 earnings on Sept. 4, 2025. The company reported GAAP revenue of $17.5 million, up from $15.0 million a year earlier, but faces margin pressure as gross margin ...

3 min read

Related tickers

More in Medical Instruments & Supplies